Investment Summary

Riverside Partners Invests In Syner-G BioPharma

On October 29, 2020, private equity firm Riverside Partners invested in life science company Syner-G BioPharma

Investment Highlights
  • This is Riverside Partners’ 2nd transaction in the Life Science sector.
  • This is Riverside Partners’ 38th transaction in the United States.
  • This is Riverside Partners’ 6th transaction in Massachusetts.

Investment Summary
Date 2020-10-29
Target Syner-G BioPharma
Sector Life Science
Investor(s) Riverside Partners
Deal Type Growth Capital
Advisor(s) Network Blue, Inc. (Financial)

Target

Syner-G BioPharma

Framingham, Massachusetts, United States
Syner-G BioPharma is a provider of customized science and risk-based CMC and regulatory solutions and services, supporting pharmaceutical and biotechnology companies across small molecule, large molecule, and cell and gene therapy products. Syner-G BioPharma is based in Framingham, Massachusetts.

Search 198,123 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Riverside Partners

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1989
PE ASSETS 1.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Riverside Partners is a specialist private equity firm focused on investments in healthcare and technology companies located throughout North America. The Firm has a particular interest in companies that are founder or family owned. Target companies are generally profitable with $3 to $15 million of EBITDA. Specific areas of interest within healthcare include suppliers to biopharmaceutical and medical device companies, medical technology and equipment, medical instrumentation, dental products and services, diagnostics and disposables, and specialized healthcare services. Areas of interest within technology include, analytical instrumentation, semiconductor equipment, industrial communications, wireless components, homeland security, and power generation technology. Transaction situations include partial or complete buyouts, recapitalizations, growth equity, divestitures, take privates, and strategic add-ons. Riverside Partners was formed in 1989 and is based in Boston, Massachusetts.

DEAL STATS #
Overall 38 of 42
Sector (Life Science) 2 of 2
Type (Growth Capital) 10 of 13
State (Massachusetts) 6 of 6
Country (United States) 38 of 42
Year (2020) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-11-19 Calero Software

Rochester, New York, United States

Calero Software is a provider of communications lifecycle management (CLM) solutions designed to turn communication data into actionable insight by simplifying the management of voice, mobile and other unified communications services and assets. Calero Software is based in Rochester, New York.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-01 Allied Dental

Toms River, New Jersey, United States

Allied Dental is a dental services organization providing management services to dental practices in the Northeast and Mid-Atlantic. Allied Dental’s practices offer a range of services from basic exams and cleanings to specialty services, including pediatrics, endodontics, periodontics, orthodontics, and oral surgery.

Sell -
Mergr

Product

Company

Legal